Примери за използване на Summary of product characteristics and the package leaflet for на Английски и техните преводи на Български
{-}
-
Colloquial
-
Official
-
Medicine
-
Ecclesiastic
-
Ecclesiastic
-
Computer
Based on this plan, safety information has been included in the summary of product characteristics and the package leaflet for Fexeric, including the appropriate precautions to be followed by healthcare.
Based on this plan, safety information has been included in the summary of product characteristics and the package leaflet for Celvapan, including the appropriate precautions to be followed by healthcare.
Safety information has been included in the summary of product characteristics and the package leaflet for Improvac, including the appropriate precautions to be followed by healthcare professionals and animal owners or keepers.
Safety information has been included in the summary of product characteristics and the package leaflet for Innovax-ILT, including the appropriate precautions to be followed by healthcare professionals and animal owners or keepers.
Safety information has been included in the summary of product characteristics and the package leaflet for Evant, including the appropriate precautions to be followed by healthcare professionals and animal owners or keepers.
Based on this plan, safety information has been included in the summary of product characteristics and the package leaflet for Odomzo, including the precautions to be followed by healthcare professionals and patients.
Safety information has been included in the summary of product characteristics and the package leaflet for Syvazul BTV,
Safety information has been included in the summary of product characteristics and the package leaflet for Simparica Trio,
Safety information has been included in the summary of product characteristics and the package leaflet for Felisecto Plus,
Safety information has been included in the summary of product characteristics and the package leaflet for MiPet Easecto,
Based on this plan, safety information has been included in the summary of product characteristics and the package leaflet for Cometriq, including the appropriate precautions to be followed by healthcare professionals and patients.
Based on this plan, safety information has been included in the summary of product characteristics and the package leaflet for Ebymect, including the appropriate precautions to be followed by healthcare professionals and patients.
Based on this plan, safety information has been included in the summary of product characteristics and the package leaflet for Vantobra, including the appropriate precautions to be followed by healthcare professionals and patients.
Safety information has been included in the summary of product characteristics and the package leaflet for Porcilis PCV ID,
Based on this plan, safety information has been included in the summary of product characteristics and the package leaflet for Peyona, including the appropriate precautions to be followed by healthcare professionals and patients.
Safety information has been included in the summary of product characteristics and the package leaflet for Porcilis PCV ID,
Based on this plan, safety information has been included in the summary of product characteristics and the package leaflet for Evarrest, including the appropriate precautions to be followed by healthcare professionals and patients.
Based on this plan, safety information has been included in the summary of product characteristics and the package leaflet for Tobi Podhaler,
Based on this plan, safety information has been included in the summary of product characteristics and the package leaflet for Thalidomide Celgene,
Based on this plan, safety information has been included in the summary of product characteristics and the package leaflet for Abilify Maintena,